318 related articles for article (PubMed ID: 36296659)
1. Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics.
Tsymbal S; Li G; Agadzhanian N; Sun Y; Zhang J; Dukhinova M; Fedorov V; Shevtsov M
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296659
[TBL] [Abstract][Full Text] [Related]
2. Targeting copper in cancer therapy: 'Copper That Cancer'.
Denoyer D; Masaldan S; La Fontaine S; Cater MA
Metallomics; 2015 Nov; 7(11):1459-76. PubMed ID: 26313539
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of copper/nickel nanoparticles using newly synthesized Schiff-base metals complexes and their cytotoxicity/catalytic activities.
Aazam ES; El-Said WA
Bioorg Chem; 2014 Dec; 57():5-12. PubMed ID: 25159596
[TBL] [Abstract][Full Text] [Related]
4. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
[TBL] [Abstract][Full Text] [Related]
5. Copper-Containing Nanoparticles and Organic Complexes: Metal Reduction Triggers Rapid Cell Death via Oxidative Burst.
Tsymbal SA; Moiseeva AA; Agadzhanian NA; Efimova SS; Markova AA; Guk DA; Krasnovskaya OO; Alpatova VM; Zaitsev AV; Shibaeva AV; Tatarskiy VV; Dukhinova MS; Ol'shevskaya VA; Ostroumova OS; Beloglazkina EK; Shtil AA
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681725
[TBL] [Abstract][Full Text] [Related]
6. Copper in tumors and the use of copper-based compounds in cancer treatment.
da Silva DA; De Luca A; Squitti R; Rongioletti M; Rossi L; Machado CML; Cerchiaro G
J Inorg Biochem; 2022 Jan; 226():111634. PubMed ID: 34740035
[TBL] [Abstract][Full Text] [Related]
7. Copper homeostasis: Emerging target for cancer treatment.
Li Y
IUBMB Life; 2020 Sep; 72(9):1900-1908. PubMed ID: 32599675
[TBL] [Abstract][Full Text] [Related]
8. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
Polyak A; Ross TL
Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
[TBL] [Abstract][Full Text] [Related]
10. A Facile and Universal Method for Preparing Polyethylene Glycol-Metal Hybrid Nanoparticles and Their Application in Tumor Theranostics.
Chen Z; Zeng Y; Chen N; Zhang M; Wang Y; Pan Z; Yuan J; Ye Z; Li X; Bian W; Li H; Zhang K; He Y; Liu X
Adv Healthc Mater; 2022 Jun; 11(12):e2200044. PubMed ID: 35192244
[TBL] [Abstract][Full Text] [Related]
11. Photoresponsive metallopolymer nanoparticles for cancer theranostics.
He M; Chen F; Shao D; Weis P; Wei Z; Sun W
Biomaterials; 2021 Aug; 275():120915. PubMed ID: 34102525
[TBL] [Abstract][Full Text] [Related]
12. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
13. Selective ion exchange governed by the Irving-Williams series in K2Zn3[Fe(CN)6]2 nanoparticles: toward a designer prodrug for Wilson's disease.
Kandanapitiye MS; Wang FJ; Valley B; Gunathilake C; Jaroniec M; Huang SD
Inorg Chem; 2015 Feb; 54(4):1212-4. PubMed ID: 25654167
[TBL] [Abstract][Full Text] [Related]
14. Transition metals and metal complexes in autophagy and diseases.
Luo Y; Fu Y; Huang Z; Li M
J Cell Physiol; 2021 Oct; 236(10):7144-7158. PubMed ID: 33694161
[TBL] [Abstract][Full Text] [Related]
15. Anticancer potency of copper(II) complexes of thiosemicarbazones.
Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
[TBL] [Abstract][Full Text] [Related]
16. A Perspective - can copper complexes be developed as a novel class of therapeutics?
Wehbe M; Leung AWY; Abrams MJ; Orvig C; Bally MB
Dalton Trans; 2017 Aug; 46(33):10758-10773. PubMed ID: 28702645
[TBL] [Abstract][Full Text] [Related]
17. Copper Complexes in Cancer Therapy.
Denoyer D; Clatworthy SAS; Cater MA
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394035
[TBL] [Abstract][Full Text] [Related]
18. Development of Copper Nanoclusters for In Vitro and In Vivo Theranostic Applications.
Lai WF; Wong WT; Rogach AL
Adv Mater; 2020 Mar; 32(9):e1906872. PubMed ID: 31975469
[TBL] [Abstract][Full Text] [Related]
19. Biochemical pathways of copper complexes: progress over the past 5 years.
Zehra S; Tabassum S; Arjmand F
Drug Discov Today; 2021 Apr; 26(4):1086-1096. PubMed ID: 33486113
[TBL] [Abstract][Full Text] [Related]
20. 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.
Zhang Z; Bi C; Schmitt SM; Fan Y; Dong L; Zuo J; Dou QP
J Biol Inorg Chem; 2012 Dec; 17(8):1257-67. PubMed ID: 23053530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
